The Reporting of A Disproportionality analysis for drUg Safety signal detection using spontaneously reported adverse events in PharmacoVigilance (READUS-PV)

被引：0
|
作者：
Fusaroli, M. [1 ]
Raschi, E. [1 ]
Salvo, F. [2 ]
Khouri, C. [3 ]
机构：
[1] Univ Bologna, Dept Med & Surg Sci, Pharmacol Unit, Bologna, Italy
[2] CHU Bordeaux, Serv Pharmacol Med, Bordeaux, France
[3] Grenoble Alpes Univ Hosp, Pharmacovigilance Unit, Grenoble, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2023年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
CO-060
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [41] Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
    Liang, Yankun
    Ma, Lin
    Wang, Yuting
    Zheng, Jingping
    Su, Ling
    Lyu, Jun
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [42] Disproportionality Analysis of Nusinersen in the Food and Drug Administration Adverse Event Reporting System: A Real-World Postmarketing Pharmacovigilance Assessment
    Li, Yanping
    Zhang, Ni
    Jiang, Tingting
    Gan, Lanlan
    Su, Hui
    Wu, Yuanlin
    Yang, Xue
    Xiang, Guiyuan
    Ni, Rui
    Xu, Jing
    Li, Chen
    Liu, Yao
    PEDIATRIC NEUROLOGY, 2024, 158 : 71 - 78
  • [43] Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Subeesh, Viswam
    Maheswari, Eswaran
    Singh, Hemendra
    Beulah, Thomas Elsa
    Swaroop, Ann Mary
    CURRENT DRUG SAFETY, 2019, 14 (01) : 21 - 26
  • [44] Signal detection for adverse events of dapagliflozin using the Korea adverse event reporting system database
    Park, Suvin
    Lee, Huieon
    Kim, Hee-Jin
    Jeong, Na-Young
    Lim, Eunsun
    Choi, Nam-Kyong
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 597 - 597
  • [45] Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data
    Wajd Alkabbani
    Ryan Pelletier
    Michael A. Beazely
    Youssef Labib
    Breanna Quan
    John-Michael Gamble
    Drug Safety, 2022, 45 : 287 - 295
  • [46] Characterization and Disproportionality Analysis of Spontaneously Reported Cases of Medication Errors to the U S-F D A Adverse Event Reporting System
    Mazhar, F.
    Carnovale, C.
    Gentili, M.
    Clementi, E.
    Radice, S.
    DRUG SAFETY, 2018, 41 (11) : 1135 - 1135
  • [47] Disproportionality analysis of cardiac adverse events associated with lenvatinib using the Japanese Adverse Drug Event Report database
    Kanbayashi, Yuko
    Kobayashi, Sakura
    Kojima, Asuka
    Wakabayashi, Haruka
    Shimizu, Tadashi
    Uchida, Mayako
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (12) : 3348 - 3354
  • [48] Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System
    Battini, Vera
    Carnovale, Carla
    Clementi, Emilio
    Sessa, Maurizio
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (11) : 1105 - 1112
  • [49] Impact of the COVID-19 pandemic on the spontaneous reporting and signal detection of adverse drug events
    Montes-Grajales, Diana
    Garcia-Serna, Ricard
    Mestres, Jordi
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [50] Impact of the COVID-19 pandemic on the spontaneous reporting and signal detection of adverse drug events
    Diana Montes-Grajales
    Ricard Garcia-Serna
    Jordi Mestres
    Scientific Reports, 13
12345